• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SIRT6 依赖的 Suv39h1 预设定结构域中的半胱氨酸单泛素化调节 NF-κB 信号通路。

SIRT6-dependent cysteine monoubiquitination in the PRE-SET domain of Suv39h1 regulates the NF-κB pathway.

作者信息

Santos-Barriopedro Irene, Bosch-Presegué Laia, Marazuela-Duque Anna, de la Torre Carolina, Colomer Carlota, Vazquez Berta N, Fuhrmann Thomas, Martínez-Pastor Bárbara, Lu Wenfu, Braun Thomas, Bober Eva, Jenuwein Thomas, Serrano Lourdes, Esteller Manel, Chen Zhenbang, Barceló-Batllori Silvia, Mostoslavsky Raúl, Espinosa Lluis, Vaquero Alejandro

机构信息

Chromatin Biology Laboratory, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Av. Gran Via de l'Hospitalet 199-203, 08908, L'Hospitalet de Llobregat (Barcelona), Spain.

Tissue Repair and Regeneration Group, Department of Biosciences, Universitat de Vic, Universitat Central de Catalunya, Barcelona, 08500, Vic, Spain.

出版信息

Nat Commun. 2018 Jan 9;9(1):101. doi: 10.1038/s41467-017-02586-x.

DOI:10.1038/s41467-017-02586-x
PMID:
29317652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5760577/
Abstract

Sirtuins are NAD-dependent deacetylases that facilitate cellular stress response. They include SirT6, which protects genome stability and regulates metabolic homeostasis through gene silencing, and whose loss induces an accelerated aging phenotype directly linked to hyperactivation of the NF-κB pathway. Here we show that SirT6 binds to the H3K9me3-specific histone methyltransferase Suv39h1 and induces monoubiquitination of conserved cysteines in the PRE-SET domain of Suv39h1. Following activation of NF-κB signaling Suv39h1 is released from the IκBα locus, subsequently repressing the NF-κB pathway. We propose that SirT6 attenuates the NF-κB pathway through IκBα upregulation via cysteine monoubiquitination and chromatin eviction of Suv39h1. We suggest a mechanism based on SirT6-mediated enhancement of a negative feedback loop that restricts the NF-κB pathway.

摘要

沉默调节蛋白是依赖烟酰胺腺嘌呤二核苷酸(NAD)的去乙酰化酶,可促进细胞应激反应。它们包括SirT6,其通过基因沉默保护基因组稳定性并调节代谢稳态,其缺失会诱导与NF-κB通路过度激活直接相关的加速衰老表型。在此,我们表明SirT6与H3K9me3特异性组蛋白甲基转移酶Suv39h1结合,并诱导Suv39h1的PRE-SET结构域中保守半胱氨酸的单泛素化。在NF-κB信号激活后,Suv39h1从IκBα基因座释放,随后抑制NF-κB通路。我们提出,SirT6通过半胱氨酸单泛素化和Suv39h1的染色质驱逐上调IκBα来减弱NF-κB通路。我们提出了一种基于SirT6介导的增强负反馈回路的机制,该回路限制了NF-κB通路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dedc/5760577/53591e7a9e8f/41467_2017_2586_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dedc/5760577/22c2f21e9700/41467_2017_2586_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dedc/5760577/3f57470513a2/41467_2017_2586_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dedc/5760577/84380f4fc1f9/41467_2017_2586_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dedc/5760577/f15108b2ea46/41467_2017_2586_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dedc/5760577/238e4280aebc/41467_2017_2586_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dedc/5760577/e53c4b202fa5/41467_2017_2586_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dedc/5760577/53591e7a9e8f/41467_2017_2586_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dedc/5760577/22c2f21e9700/41467_2017_2586_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dedc/5760577/3f57470513a2/41467_2017_2586_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dedc/5760577/84380f4fc1f9/41467_2017_2586_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dedc/5760577/f15108b2ea46/41467_2017_2586_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dedc/5760577/238e4280aebc/41467_2017_2586_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dedc/5760577/e53c4b202fa5/41467_2017_2586_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dedc/5760577/53591e7a9e8f/41467_2017_2586_Fig7_HTML.jpg

相似文献

1
SIRT6-dependent cysteine monoubiquitination in the PRE-SET domain of Suv39h1 regulates the NF-κB pathway.SIRT6 依赖的 Suv39h1 预设定结构域中的半胱氨酸单泛素化调节 NF-κB 信号通路。
Nat Commun. 2018 Jan 9;9(1):101. doi: 10.1038/s41467-017-02586-x.
2
Complex role of SIRT6 in NF-κB pathway regulation.SIRT6在NF-κB信号通路调控中的复杂作用
Mol Cell Oncol. 2018 May 24;5(4):e1445942. doi: 10.1080/23723556.2018.1445942. eCollection 2018.
3
SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation.在异染色质形成过程中,SIRT1调节组蛋白甲基转移酶SUV39H1。
Nature. 2007 Nov 15;450(7168):440-4. doi: 10.1038/nature06268.
4
Stabilization of Suv39H1 by SirT1 is part of oxidative stress response and ensures genome protection.SirT1 稳定 Suv39H1 是氧化应激反应的一部分,可确保基因组的保护。
Mol Cell. 2011 Apr 22;42(2):210-23. doi: 10.1016/j.molcel.2011.02.034.
5
SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span.SIRT6将组蛋白H3赖氨酸9去乙酰化与NF-κB依赖的基因表达及生物体寿命联系起来。
Cell. 2009 Jan 9;136(1):62-74. doi: 10.1016/j.cell.2008.10.052.
6
Icariin intervenes in cardiac inflammaging through upregulation of SIRT6 enzyme activity and inhibition of the NF-kappa B pathway.淫羊藿苷通过上调SIRT6酶活性和抑制NF-κB信号通路干预心脏炎症衰老。
Biomed Res Int. 2015;2015:895976. doi: 10.1155/2015/895976. Epub 2015 Jan 20.
7
An HP1 isoform-specific feedback mechanism regulates Suv39h1 activity under stress conditions.一种HP1亚型特异性反馈机制在应激条件下调节Suv39h1活性。
Epigenetics. 2017 Feb;12(2):166-175. doi: 10.1080/15592294.2016.1278096. Epub 2017 Jan 6.
8
Calorie restriction-induced SIRT6 activation delays aging by suppressing NF-κB signaling.热量限制诱导的SIRT6激活通过抑制NF-κB信号传导延缓衰老。
Cell Cycle. 2016;15(7):1009-18. doi: 10.1080/15384101.2016.1152427.
9
Prolyl isomerase Pin1 negatively regulates the stability of SUV39H1 to promote tumorigenesis in breast cancer.脯氨酰异构酶 Pin1 负调控 SUV39H1 的稳定性,促进乳腺癌发生。
FASEB J. 2013 Nov;27(11):4606-18. doi: 10.1096/fj.13-236851. Epub 2013 Aug 9.
10
TRIM45 negatively regulates NF-κB-mediated transcription and suppresses cell proliferation.TRIM45 负向调节 NF-κB 介导的转录并抑制细胞增殖。
Biochem Biophys Res Commun. 2012 Jun 22;423(1):104-9. doi: 10.1016/j.bbrc.2012.05.090. Epub 2012 May 23.

引用本文的文献

1
SIRT6 alleviates senescence induced by Porphyromonas gingivalis in human gingival fibroblasts.SIRT6 减轻牙龈卟啉单胞菌引起的人牙龈成纤维细胞衰老。
Mol Biol Rep. 2024 Sep 11;51(1):976. doi: 10.1007/s11033-024-09913-8.
2
Research progress of SIRTs activator resveratrol and its derivatives in autoimmune diseases.SIRTs 激活剂白藜芦醇及其衍生物在自身免疫性疾病中的研究进展。
Front Immunol. 2024 Jun 19;15:1390907. doi: 10.3389/fimmu.2024.1390907. eCollection 2024.
3
SIRT6 in Regulation of Mitochondrial Damage and Associated Cardiac Dysfunctions: A Possible Therapeutic Target for CVDs.

本文引用的文献

1
The Substrate Specificity of Sirtuins.去乙酰化酶的底物特异性。
Annu Rev Biochem. 2016 Jun 2;85:405-29. doi: 10.1146/annurev-biochem-060815-014537. Epub 2016 Apr 18.
2
SKP2 inactivation suppresses prostate tumorigenesis by mediating JARID1B ubiquitination.SKP2失活通过介导JARID1B泛素化抑制前列腺肿瘤发生。
Oncotarget. 2015 Jan 20;6(2):771-88. doi: 10.18632/oncotarget.2718.
3
MDM2-mediated degradation of SIRT6 phosphorylated by AKT1 promotes tumorigenesis and trastuzumab resistance in breast cancer.由AKT1磷酸化的SIRT6经MDM2介导的降解促进乳腺癌的肿瘤发生和曲妥珠单抗耐药。
SIRT6 在调控线粒体损伤及相关心脏功能障碍中的作用:CVD 的一个潜在治疗靶点。
Cardiovasc Toxicol. 2024 Jun;24(6):598-621. doi: 10.1007/s12012-024-09858-1. Epub 2024 Apr 30.
4
Inhibition of SUV39H1 reduces tumor angiogenesis via Notch1 in oral squamous cell carcinoma.SUV39H1 的抑制通过 Notch1 减少口腔鳞状细胞癌中的肿瘤血管生成。
PeerJ. 2024 Apr 19;12:e17222. doi: 10.7717/peerj.17222. eCollection 2024.
5
Noncanonical and reversible cysteine ubiquitination prevents the overubiquitination of PEX5 at the peroxisomal membrane.非典型的、可逆的半胱氨酸泛素化可以防止过氧化物酶体膜上 PEX5 的过度泛素化。
PLoS Biol. 2024 Mar 12;22(3):e3002567. doi: 10.1371/journal.pbio.3002567. eCollection 2024 Mar.
6
and functional validation of imidazole derivatives as potential sirtuin inhibitor.咪唑衍生物作为潜在的沉默调节蛋白抑制剂的功能验证
Front Med (Lausanne). 2023 Nov 7;10:1282820. doi: 10.3389/fmed.2023.1282820. eCollection 2023.
7
Serum SIRT6 Levels Are Associated with Frailty in Older Adults.血清 SIRT6 水平与老年人虚弱有关。
J Nutr Health Aging. 2023;27(9):719-725. doi: 10.1007/s12603-023-1969-y.
8
The role of mammalian Sirtuin 6 in cardiovascular diseases and diabetes mellitus.哺乳动物沉默调节蛋白6在心血管疾病和糖尿病中的作用。
Front Physiol. 2023 Jul 11;14:1207133. doi: 10.3389/fphys.2023.1207133. eCollection 2023.
9
SIRT6 in Aging, Metabolism, Inflammation and Cardiovascular Diseases.衰老、代谢、炎症及心血管疾病中的SIRT6
Aging Dis. 2022 Dec 1;13(6):1787-1822. doi: 10.14336/AD.2022.0413.
10
SIRT6 promotes ferroptosis and attenuates glycolysis in pancreatic cancer through regulation of the NF-κB pathway.SIRT6通过调节NF-κB通路促进胰腺癌的铁死亡并减弱糖酵解。
Exp Ther Med. 2022 Jun 8;24(2):502. doi: 10.3892/etm.2022.11430. eCollection 2022 Aug.
Sci Signal. 2014 Jul 29;7(336):ra71. doi: 10.1126/scisignal.2005076.
4
NAD+ and sirtuins in aging and disease.衰老与疾病中的烟酰胺腺嘌呤二核苷酸(NAD+)和沉默调节蛋白
Trends Cell Biol. 2014 Aug;24(8):464-71. doi: 10.1016/j.tcb.2014.04.002. Epub 2014 Apr 29.
5
Comparative interactomes of SIRT6 and SIRT7: Implication of functional links to aging.SIRT6和SIRT7的比较相互作用组:与衰老功能联系的意义。
Proteomics. 2014 Jul;14(13-14):1610-22. doi: 10.1002/pmic.201400001. Epub 2014 May 28.
6
Cracking the NF-κB code.破解 NF-κB 密码。
Sci Signal. 2014 Feb 18;7(313):pe5. doi: 10.1126/scisignal.2005108.
7
A proteomic perspective of Sirtuin 6 (SIRT6) phosphorylation and interactions and their dependence on its catalytic activity.从蛋白质组学角度探讨 Sirtuin 6(SIRT6)的磷酸化和相互作用及其对其催化活性的依赖性。
Mol Cell Proteomics. 2014 Jan;13(1):168-83. doi: 10.1074/mcp.M113.032847. Epub 2013 Oct 25.
8
The ubiquitin ligase CHIP prevents SirT6 degradation through noncanonical ubiquitination.泛素连接酶 CHIP 通过非典型泛素化防止 SirT6 降解。
Mol Cell Biol. 2013 Nov;33(22):4461-72. doi: 10.1128/MCB.00480-13. Epub 2013 Sep 16.
9
The diversity of histone versus nonhistone sirtuin substrates.组蛋白与非组蛋白沉默调节蛋白底物的多样性。
Genes Cancer. 2013 Mar;4(3-4):148-63. doi: 10.1177/1947601913483767.
10
Sirtuins in stress response: guardians of the genome.应激反应中的 Sirtuins:基因组的守护者。
Oncogene. 2014 Jul 17;33(29):3764-75. doi: 10.1038/onc.2013.344. Epub 2013 Sep 2.